These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17013849)

  • 41. [Thoughts on the "COX-2 story"].
    Kurz H
    Wien Med Wochenschr; 2005 May; 155(9-10):205-6. PubMed ID: 15999626
    [No Abstract]   [Full Text] [Related]  

  • 42. Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.
    Lim YJ; Lee JS; Ku YS; Hahm KB
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1169-78. PubMed ID: 19682191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage regulation by arachidonic acid metabolites: can this physiological control process serve as a model for novel pharmacotherapy of immuno-inflammatory conditions?
    Bonta IL
    Agents Actions Suppl; 1984; 14():5-19. PubMed ID: 6433682
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclooxygenase-2 inhibitors dilemma in cardiovascular medicine: are all family members bad players?
    Celik T; Iyisoy A; Kursaklioglu H; Yuksel UC
    Int J Cardiol; 2007 Mar; 116(2):259-60. PubMed ID: 16837083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coxarthrosis: etiology, epidemiology, clinical manifestations and new approaches to therapy].
    Makolkin VI; Pak IuV; Men'shikova IV
    Ter Arkh; 2007; 79(1):81-5. PubMed ID: 17385474
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
    Hennekens CH; Borzak S
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
    Boers M
    Arthritis Rheum; 2007 Jan; 56(1):384; author reply 384. PubMed ID: 17195242
    [No Abstract]   [Full Text] [Related]  

  • 48. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE; Metge CJ; Leung S; Chateau DG
    Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".
    Cen YY
    Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275
    [No Abstract]   [Full Text] [Related]  

  • 50. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib.
    Urdaneta A; Siso A; Urdaneta B; Cardenas R; Quintero L; Avila R; Suarez-Roca H
    Brain Res Bull; 2009 Aug; 80(1-2):56-61. PubMed ID: 19463915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-steroidal anti-inflammatory drugs--changes in prescribing may be warranted.
    Madhok R; Wu O; McKellar G; Singh G
    Rheumatology (Oxford); 2006 Dec; 45(12):1458-60. PubMed ID: 17077156
    [No Abstract]   [Full Text] [Related]  

  • 52. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?
    Boursinos LA; Karachalios T; Poultsides L; Malizos KN
    J Musculoskelet Neuronal Interact; 2009; 9(1):44-52. PubMed ID: 19240368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Boswellic acids (the active agent in incense) for the treatment of chronic inflammatory diseases].
    Ammon HP
    Med Monatsschr Pharm; 2003 Sep; 26(9):309-15. PubMed ID: 14526615
    [No Abstract]   [Full Text] [Related]  

  • 54. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 55. Inflammatory resolution: new opportunities for drug discovery.
    Gilroy DW; Lawrence T; Perretti M; Rossi AG
    Nat Rev Drug Discov; 2004 May; 3(5):401-16. PubMed ID: 15136788
    [No Abstract]   [Full Text] [Related]  

  • 56. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonsteroidal anti-inflammatory drugs: are they safe after joint arthroplasty for early pain?
    Purtill JJ
    Instr Course Lect; 2007; 56():133-7. PubMed ID: 17472301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety update: a year after Vioxx.
    Johns Hopkins Med Lett Health After 50; 2005 Dec; 17(10):1-2. PubMed ID: 16435424
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunoinflammatory responses in gastrointestinal tract injury and recovery.
    Verma G; Marella A; Shaquiquzzaman M; Alam MM
    Acta Biochim Pol; 2013; 60(2):143-9. PubMed ID: 23757446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.